Stress, Glucocorticoids and Alzheimer Disease
压力、糖皮质激素和阿尔茨海默病
基本信息
- 批准号:7116719
- 负责人:
- 金额:$ 33.7万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2005
- 资助国家:美国
- 起止时间:2005-09-01 至 2010-08-31
- 项目状态:已结题
- 来源:
- 关键词:Alzheimer&aposs diseaseamyloid proteinsbehavioral /social science research tagbrain mappingbrain morphologyclinical researchcortisolenzyme linked immunosorbent assaygenetically modified animalsglucocorticoidshippocampushormone regulation /control mechanismhuman old age (65+)human subjectinterviewlaboratory mouselongitudinal human studymicrodialysisneuroendocrine systemneuropathologyneuropsychological testspathologic processpsychological aspect of agingpsychological stressorwhite matter
项目摘要
DESCRIPTION (provided by applicant): Alzheimer disease (AD) is a progressive neurodegenerative disease and the most common cause for dementia in the elderly. Among patients with AD, the rate of disease progression varies considerably, related in some degree to stage of illness and comorbid medical conditions. Psychological stress is well known to increase activity of the hypothalamic-pituitary-adrenal (HP A) axis by promoting release of glucocorticoid (GC) hormones in a variety of mammalian species, and chronically increased levels of GC hormones have been associated with decreases in hippocampal volume and memory deficits. Associations between stress, increased GC activity and hippocampal degeneration may have special relevance for understanding the neurobiology of AD, since hippocampal degeneration is also a marker of early AD. However, there have been few investigations of the relationship between stress, GC hormones and the progression of AD.
The overall aim of this project is to investigate the general hypothesis that stress, by increasing GC levels, accelerates the rate of progression of AD. In preliminary work, we have made two key findings that support this general hypothesis. First, in a study of patients with very mild-to-mild dementia of the Alzheimer type (DAT), we found a correlation between SAM serum cortisol concentrations and the rate of change of clinical and neuropsychological measures of dementia. Second, in Tg2576 mice that overproduce the human form of amyloid precursor protein (APP), chronic isolation stress increased serum levels of corticosterone, the severity of deficits in contextual memory, and the rate of deposition of a-amyloid plaques in the hippocampus and cortex.
We now propose to further investigate the general hypothesis that stress can accelerate the rate of progression of AD via increases in GC activity. First, we propose to assess correlations between blood and salivary cortisol levels and the rate of disease progression in DAT subjects measured using neuroanatomical as well as clinical and neuropsychological measures. Second, we propose to investigate the mechanism(s) by which isolation stress increases the rate of beta-amyloid plaque deposition in APP-transgenic mice, and in specific, to determine the degree to which GC hormones are an element of this mechanism.
描述(由申请人提供): 阿尔茨海默病(Alzheimer disease,AD)是一种进行性神经退行性疾病,是老年人痴呆的最常见原因。在AD患者中,疾病进展的速度差异很大,在一定程度上与疾病的分期和合并症有关。众所周知,心理应激通过促进各种哺乳动物物种中糖皮质激素(GC)激素的释放来增加下丘脑-垂体-肾上腺(HPA)轴的活性,并且GC激素水平的长期增加与海马体积和记忆缺陷的减少相关。应激、GC活性增加和海马变性之间的关联对于理解AD的神经生物学可能具有特殊的相关性,因为海马变性也是早期AD的标志。然而,关于应激、GC激素和AD进展之间的关系的研究很少。
该项目的总体目标是调查压力通过增加GC水平加速AD进展速度的一般假设。在初步工作中,我们有两个关键发现支持这一一般假设。首先,在一项对阿尔茨海默型(DAT)极轻度至轻度痴呆患者的研究中,我们发现SAM血清皮质醇浓度与痴呆的临床和神经心理学指标变化率之间存在相关性。第二,在过度产生人类形式的淀粉样前体蛋白(APP)的Tg 2576小鼠中,慢性隔离应激增加了血清皮质酮水平、背景记忆缺陷的严重程度以及海马和皮质中α-淀粉样蛋白斑块的沉积速率。
我们现在建议进一步研究的一般假设,即压力可以通过增加GC活性加速AD的进展速度。首先,我们建议使用神经解剖学以及临床和神经心理学措施来评估血液和唾液皮质醇水平与DAT受试者疾病进展率之间的相关性。其次,我们建议调查隔离应激增加APP转基因小鼠中β-淀粉样蛋白斑块沉积速率的机制,具体而言,确定GC激素在多大程度上是这种机制的一个要素。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JOHN G CSERNANSKY其他文献
JOHN G CSERNANSKY的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JOHN G CSERNANSKY', 18)}}的其他基金
Post-Graduate Research Training Aligned with the NIMH Strategic Plan
符合 NIMH 战略计划的研究生研究培训
- 批准号:
10115122 - 财政年份:2019
- 资助金额:
$ 33.7万 - 项目类别:
NEUROMORPHOMETRY IN SIBLINGS AT RISK FOR SCHIZOPHRENIA
对有精神分裂症风险的兄弟姐妹进行神经形态测量
- 批准号:
7476360 - 财政年份:2007
- 资助金额:
$ 33.7万 - 项目类别:
NEUROMORPHOMETRY IN SCHIZOPHRENIA BY COMPUTER ALGORITHM, ALZ BY BRAIN MAPPING
通过计算机算法进行精神分裂症的神经形态测量,通过脑图绘制 ALZ
- 批准号:
7420422 - 财政年份:2006
- 资助金额:
$ 33.7万 - 项目类别:
NEUROMORPHOMETRY IN SCHIZOPHRENIA BY COMPUTER ALGORITHM, ALZ BY BRAIN MAPPING
通过计算机算法进行精神分裂症的神经形态测量,通过脑图绘制 ALZ
- 批准号:
7182872 - 财政年份:2005
- 资助金额:
$ 33.7万 - 项目类别:
相似国自然基金
新型F-18标记香豆素衍生物PET探针的研制及靶向Alzheimer's Disease 斑块显像研究
- 批准号:81000622
- 批准年份:2010
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
阿尔茨海默病(Alzheimer's disease,AD)动物模型构建的分子机理研究
- 批准号:31060293
- 批准年份:2010
- 资助金额:26.0 万元
- 项目类别:地区科学基金项目
跨膜转运蛋白21(TMP21)对引起阿尔茨海默病(Alzheimer'S Disease)的γ分泌酶的作用研究
- 批准号:30960334
- 批准年份:2009
- 资助金额:22.0 万元
- 项目类别:地区科学基金项目
相似海外基金
Pathophysiological mechanisms of hypoperfusion in mouse models of Alzheimer?s disease and small vessel disease
阿尔茨海默病和小血管疾病小鼠模型低灌注的病理生理机制
- 批准号:
10657993 - 财政年份:2023
- 资助金额:
$ 33.7万 - 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
- 批准号:
10381163 - 财政年份:2022
- 资助金额:
$ 33.7万 - 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
- 批准号:
10531959 - 财政年份:2022
- 资助金额:
$ 33.7万 - 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
- 批准号:
10700991 - 财政年份:2022
- 资助金额:
$ 33.7万 - 项目类别:
Interneurons as early drivers of Huntington´s disease progression
中间神经元是亨廷顿病进展的早期驱动因素
- 批准号:
10518582 - 财政年份:2022
- 资助金额:
$ 33.7万 - 项目类别:
Interneurons as Early Drivers of Huntington´s Disease Progression
中间神经元是亨廷顿病进展的早期驱动因素
- 批准号:
10672973 - 财政年份:2022
- 资助金额:
$ 33.7万 - 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
- 批准号:
10585925 - 财政年份:2022
- 资助金额:
$ 33.7万 - 项目类别:
Oligodendrocyte heterogeneity in Alzheimer' s disease
阿尔茨海默病中的少突胶质细胞异质性
- 批准号:
10180000 - 财政年份:2021
- 资助金额:
$ 33.7万 - 项目类别:
Serum proteome analysis of Alzheimer´s disease in a population-based longitudinal cohort study - the AGES Reykjavik study
基于人群的纵向队列研究中阿尔茨海默病的血清蛋白质组分析 - AGES 雷克雅未克研究
- 批准号:
10049426 - 财政年份:2021
- 资助金额:
$ 33.7万 - 项目类别:
Repurposing drugs for Alzheimer´s disease using a reverse translational approach
使用逆翻译方法重新利用治疗阿尔茨海默病的药物
- 批准号:
10295809 - 财政年份:2021
- 资助金额:
$ 33.7万 - 项目类别: